T45 Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified

Codes

• T45.0Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs

  • T45.0XPoisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs

    • T45.0X1Poisoning by antiallergic and antiemetic drugs, accidental (unintentional)

      • T45.0X1A..., initial encounter
      • T45.0X1D..., subsequent encounter
      • T45.0X1S..., sequela
    • T45.0X2Poisoning by antiallergic and antiemetic drugs, intentional self-harm

      • T45.0X2A..., initial encounter
      • T45.0X2D..., subsequent encounter
      • T45.0X2S..., sequela
    • T45.0X3Poisoning by antiallergic and antiemetic drugs, assault

      • T45.0X3A..., initial encounter
      • T45.0X3D..., subsequent encounter
      • T45.0X3S..., sequela
    • T45.0X4Poisoning by antiallergic and antiemetic drugs, undetermined

      • T45.0X4A..., initial encounter
      • T45.0X4D..., subsequent encounter
      • T45.0X4S..., sequela
    • T45.0X5Adverse effect of antiallergic and antiemetic drugs

      • T45.0X5A..., initial encounter
      • T45.0X5D..., subsequent encounter
      • T45.0X5S..., sequela
    • T45.0X6Underdosing of antiallergic and antiemetic drugs

      • T45.0X6A..., initial encounter
      • T45.0X6D..., subsequent encounter
      • T45.0X6S..., sequela
• T45.1Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs

  • T45.1XPoisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs

    • T45.1X1Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional)

      • T45.1X1A..., initial encounter
      • T45.1X1D..., subsequent encounter
      • T45.1X1S..., sequela
    • T45.1X2Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm

      • T45.1X2A..., initial encounter
      • T45.1X2D..., subsequent encounter
      • T45.1X2S..., sequela
    • T45.1X3Poisoning by antineoplastic and immunosuppressive drugs, assault

      • T45.1X3A..., initial encounter
      • T45.1X3D..., subsequent encounter
      • T45.1X3S..., sequela
    • T45.1X4Poisoning by antineoplastic and immunosuppressive drugs, undetermined

      • T45.1X4A..., initial encounter
      • T45.1X4D..., subsequent encounter
      • T45.1X4S..., sequela
    • T45.1X5Adverse effect of antineoplastic and immunosuppressive drugs

      • T45.1X5A..., initial encounter
      • T45.1X5D..., subsequent encounter
      • T45.1X5S..., sequela
    • T45.1X6Underdosing of antineoplastic and immunosuppressive drugs

      • T45.1X6A..., initial encounter
      • T45.1X6D..., subsequent encounter
      • T45.1X6S..., sequela
• T45.2Poisoning by, adverse effect of and underdosing of vitamins

  • T45.2XPoisoning by, adverse effect of and underdosing of vitamins

    • T45.2X1Poisoning by vitamins, accidental (unintentional)

      • T45.2X1A..., initial encounter
      • T45.2X1D..., subsequent encounter
      • T45.2X1S..., sequela
    • T45.2X2Poisoning by vitamins, intentional self-harm

      • T45.2X2A..., initial encounter
      • T45.2X2D..., subsequent encounter
      • T45.2X2S..., sequela
    • T45.2X3Poisoning by vitamins, assault

      • T45.2X3A..., initial encounter
      • T45.2X3D..., subsequent encounter
      • T45.2X3S..., sequela
    • T45.2X4Poisoning by vitamins, undetermined

      • T45.2X4A..., initial encounter
      • T45.2X4D..., subsequent encounter
      • T45.2X4S..., sequela
    • T45.2X5Adverse effect of vitamins

      • T45.2X5A..., initial encounter
      • T45.2X5D..., subsequent encounter
      • T45.2X5S..., sequela
    • T45.2X6Underdosing of vitamins

      • T45.2X6A..., initial encounter
      • T45.2X6D..., subsequent encounter
      • T45.2X6S..., sequela
• T45.3Poisoning by, adverse effect of and underdosing of enzymes

  • T45.3XPoisoning by, adverse effect of and underdosing of enzymes

    • T45.3X1Poisoning by enzymes, accidental (unintentional)

      • T45.3X1A..., initial encounter
      • T45.3X1D..., subsequent encounter
      • T45.3X1S..., sequela
    • T45.3X2Poisoning by enzymes, intentional self-harm

      • T45.3X2A..., initial encounter
      • T45.3X2D..., subsequent encounter
      • T45.3X2S..., sequela
    • T45.3X3Poisoning by enzymes, assault

      • T45.3X3A..., initial encounter
      • T45.3X3D..., subsequent encounter
      • T45.3X3S..., sequela
    • T45.3X4Poisoning by enzymes, undetermined

      • T45.3X4A..., initial encounter
      • T45.3X4D..., subsequent encounter
      • T45.3X4S..., sequela
    • T45.3X5Adverse effect of enzymes

      • T45.3X5A..., initial encounter
      • T45.3X5D..., subsequent encounter
      • T45.3X5S..., sequela
    • T45.3X6Underdosing of enzymes

      • T45.3X6A..., initial encounter
      • T45.3X6D..., subsequent encounter
      • T45.3X6S..., sequela
• T45.4Poisoning by, adverse effect of and underdosing of iron and its compounds

  • T45.4XPoisoning by, adverse effect of and underdosing of iron and its compounds

    • T45.4X1Poisoning by iron and its compounds, accidental (unintentional)

      • T45.4X1A..., initial encounter
      • T45.4X1D..., subsequent encounter
      • T45.4X1S..., sequela
    • T45.4X2Poisoning by iron and its compounds, intentional self-harm

      • T45.4X2A..., initial encounter
      • T45.4X2D..., subsequent encounter
      • T45.4X2S..., sequela
    • T45.4X3Poisoning by iron and its compounds, assault

      • T45.4X3A..., initial encounter
      • T45.4X3D..., subsequent encounter
      • T45.4X3S..., sequela
    • T45.4X4Poisoning by iron and its compounds, undetermined

      • T45.4X4A..., initial encounter
      • T45.4X4D..., subsequent encounter
      • T45.4X4S..., sequela
    • T45.4X5Adverse effect of iron and its compounds

      • T45.4X5A..., initial encounter
      • T45.4X5D..., subsequent encounter
      • T45.4X5S..., sequela
    • T45.4X6Underdosing of iron and its compounds

      • T45.4X6A..., initial encounter
      • T45.4X6D..., subsequent encounter
      • T45.4X6S..., sequela
• T45.5Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs

  • T45.51Poisoning by, adverse effect of and underdosing of anticoagulants

    • T45.511Poisoning by anticoagulants, accidental (unintentional)

      • T45.511A..., initial encounter
      • T45.511D..., subsequent encounter
      • T45.511S..., sequela
    • T45.512Poisoning by anticoagulants, intentional self-harm

      • T45.512A..., initial encounter
      • T45.512D..., subsequent encounter
      • T45.512S..., sequela
    • T45.513Poisoning by anticoagulants, assault

      • T45.513A..., initial encounter
      • T45.513D..., subsequent encounter
      • T45.513S..., sequela
    • T45.514Poisoning by anticoagulants, undetermined

      • T45.514A..., initial encounter
      • T45.514D..., subsequent encounter
      • T45.514S..., sequela
    • T45.515Adverse effect of anticoagulants

      • T45.515A..., initial encounter
      • T45.515D..., subsequent encounter
      • T45.515S..., sequela
    • T45.516Underdosing of anticoagulants

      • T45.516A..., initial encounter
      • T45.516D..., subsequent encounter
      • T45.516S..., sequela
  • T45.52Poisoning by, adverse effect of and underdosing of antithrombotic drugs

    • T45.521Poisoning by antithrombotic drugs, accidental (unintentional)

      • T45.521A..., initial encounter
      • T45.521D..., subsequent encounter
      • T45.521S..., sequela
    • T45.522Poisoning by antithrombotic drugs, intentional self-harm

      • T45.522A..., initial encounter
      • T45.522D..., subsequent encounter
      • T45.522S..., sequela
    • T45.523Poisoning by antithrombotic drugs, assault

      • T45.523A..., initial encounter
      • T45.523D..., subsequent encounter
      • T45.523S..., sequela
    • T45.524Poisoning by antithrombotic drugs, undetermined

      • T45.524A..., initial encounter
      • T45.524D..., subsequent encounter
      • T45.524S..., sequela
    • T45.525Adverse effect of antithrombotic drugs

      • T45.525A..., initial encounter
      • T45.525D..., subsequent encounter
      • T45.525S..., sequela
    • T45.526Underdosing of antithrombotic drugs

      • T45.526A..., initial encounter
      • T45.526D..., subsequent encounter
      • T45.526S..., sequela
• T45.6Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs

  • T45.60Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs

    • T45.601Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional)

      • T45.601A..., initial encounter
      • T45.601D..., subsequent encounter
      • T45.601S..., sequela
    • T45.602Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm

      • T45.602A..., initial encounter
      • T45.602D..., subsequent encounter
      • T45.602S..., sequela
    • T45.603Poisoning by unspecified fibrinolysis-affecting drugs, assault

      • T45.603A..., initial encounter
      • T45.603D..., subsequent encounter
      • T45.603S..., sequela
    • T45.604Poisoning by unspecified fibrinolysis-affecting drugs, undetermined

      • T45.604A..., initial encounter
      • T45.604D..., subsequent encounter
      • T45.604S..., sequela
    • T45.605Adverse effect of unspecified fibrinolysis-affecting drugs

      • T45.605A..., initial encounter
      • T45.605D..., subsequent encounter
      • T45.605S..., sequela
    • T45.606Underdosing of unspecified fibrinolysis-affecting drugs

      • T45.606A..., initial encounter
      • T45.606D..., subsequent encounter
      • T45.606S..., sequela
  • T45.61Poisoning by, adverse effect of and underdosing of thrombolytic drugs

    • T45.611Poisoning by thrombolytic drug, accidental (unintentional)

      • T45.611A..., initial encounter
      • T45.611D..., subsequent encounter
      • T45.611S..., sequela
    • T45.612Poisoning by thrombolytic drug, intentional self-harm

      • T45.612A..., initial encounter
      • T45.612D..., subsequent encounter
      • T45.612S..., sequela
    • T45.613Poisoning by thrombolytic drug, assault

      • T45.613A..., initial encounter
      • T45.613D..., subsequent encounter
      • T45.613S..., sequela
    • T45.614Poisoning by thrombolytic drug, undetermined

      • T45.614A..., initial encounter
      • T45.614D..., subsequent encounter
      • T45.614S..., sequela
    • T45.615Adverse effect of thrombolytic drugs

      • T45.615A..., initial encounter
      • T45.615D..., subsequent encounter
      • T45.615S..., sequela
    • T45.616Underdosing of thrombolytic drugs

      • T45.616A..., initial encounter
      • T45.616D..., subsequent encounter
      • T45.616S..., sequela
  • T45.62Poisoning by, adverse effect of and underdosing of hemostatic drugs

    • T45.621Poisoning by hemostatic drug, accidental (unintentional)

      • T45.621A..., initial encounter
      • T45.621D..., subsequent encounter
      • T45.621S..., sequela
    • T45.622Poisoning by hemostatic drug, intentional self-harm

      • T45.622A..., initial encounter
      • T45.622D..., subsequent encounter
      • T45.622S..., sequela
    • T45.623Poisoning by hemostatic drug, assault

      • T45.623A..., initial encounter
      • T45.623D..., subsequent encounter
      • T45.623S..., sequela
    • T45.624Poisoning by hemostatic drug, undetermined

      • T45.624A..., initial encounter
      • T45.624D..., subsequent encounter
      • T45.624S..., sequela
    • T45.625Adverse effect of hemostatic drug

      • T45.625A..., initial encounter
      • T45.625D..., subsequent encounter
      • T45.625S..., sequela
    • T45.626Underdosing of hemostatic drugs

      • T45.626A..., initial encounter
      • T45.626D..., subsequent encounter
      • T45.626S..., sequela
  • T45.69Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs

    • T45.691Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional)

      • T45.691A..., initial encounter
      • T45.691D..., subsequent encounter
      • T45.691S..., sequela
    • T45.692Poisoning by other fibrinolysis-affecting drugs, intentional self-harm

      • T45.692A..., initial encounter
      • T45.692D..., subsequent encounter
      • T45.692S..., sequela
    • T45.693Poisoning by other fibrinolysis-affecting drugs, assault

      • T45.693A..., initial encounter
      • T45.693D..., subsequent encounter
      • T45.693S..., sequela
    • T45.694Poisoning by other fibrinolysis-affecting drugs, undetermined

      • T45.694A..., initial encounter
      • T45.694D..., subsequent encounter
      • T45.694S..., sequela
    • T45.695Adverse effect of other fibrinolysis-affecting drugs

      • T45.695A..., initial encounter
      • T45.695D..., subsequent encounter
      • T45.695S..., sequela
    • T45.696Underdosing of other fibrinolysis-affecting drugs

      • T45.696A..., initial encounter
      • T45.696D..., subsequent encounter
      • T45.696S..., sequela
• T45.7Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants

  • T45.7XPoisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants

    • T45.7X1Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional)

      • T45.7X1A..., initial encounter
      • T45.7X1D..., subsequent encounter
      • T45.7X1S..., sequela
    • T45.7X2Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm

      • T45.7X2A..., initial encounter
      • T45.7X2D..., subsequent encounter
      • T45.7X2S..., sequela
    • T45.7X3Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault

      • T45.7X3A..., initial encounter
      • T45.7X3D..., subsequent encounter
      • T45.7X3S..., sequela
    • T45.7X4Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined

      • T45.7X4A..., initial encounter
      • T45.7X4D..., subsequent encounter
      • T45.7X4S..., sequela
    • T45.7X5Adverse effect of anticoagulant antagonists, vitamin K and other coagulants

      • T45.7X5A..., initial encounter
      • T45.7X5D..., subsequent encounter
      • T45.7X5S..., sequela
    • T45.7X6Underdosing of anticoagulant antagonist, vitamin K and other coagulants

      • T45.7X6A..., initial encounter
      • T45.7X6D..., subsequent encounter
      • T45.7X6S..., sequela
• T45.8Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents

  • T45.8XPoisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents

    • T45.8X1Poisoning by other primarily systemic and hematological agents, accidental (unintentional)

      • T45.8X1A..., initial encounter
      • T45.8X1D..., subsequent encounter
      • T45.8X1S..., sequela
    • T45.8X2Poisoning by other primarily systemic and hematological agents, intentional self-harm

      • T45.8X2A..., initial encounter
      • T45.8X2D..., subsequent encounter
      • T45.8X2S..., sequela
    • T45.8X3Poisoning by other primarily systemic and hematological agents, assault

      • T45.8X3A..., initial encounter
      • T45.8X3D..., subsequent encounter
      • T45.8X3S..., sequela
    • T45.8X4Poisoning by other primarily systemic and hematological agents, undetermined

      • T45.8X4A..., initial encounter
      • T45.8X4D..., subsequent encounter
      • T45.8X4S..., sequela
    • T45.8X5Adverse effect of other primarily systemic and hematological agents

      • T45.8X5A..., initial encounter
      • T45.8X5D..., subsequent encounter
      • T45.8X5S..., sequela
    • T45.8X6Underdosing of other primarily systemic and hematological agents

      • T45.8X6A..., initial encounter
      • T45.8X6D..., subsequent encounter
      • T45.8X6S..., sequela
• T45.9Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent

  • T45.91Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional)

    • T45.91XA..., initial encounter
    • T45.91XD..., subsequent encounter
    • T45.91XS..., sequela
  • T45.92Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm

    • T45.92XA..., initial encounter
    • T45.92XD..., subsequent encounter
    • T45.92XS..., sequela
  • T45.93Poisoning by unspecified primarily systemic and hematological agent, assault

    • T45.93XA..., initial encounter
    • T45.93XD..., subsequent encounter
    • T45.93XS..., sequela
  • T45.94Poisoning by unspecified primarily systemic and hematological agent, undetermined

    • T45.94XA..., initial encounter
    • T45.94XD..., subsequent encounter
    • T45.94XS..., sequela
  • T45.95Adverse effect of unspecified primarily systemic and hematological agent

    • T45.95XA..., initial encounter
    • T45.95XD..., subsequent encounter
    • T45.95XS..., sequela
  • T45.96Underdosing of unspecified primarily systemic and hematological agent

    • T45.96XA..., initial encounter
    • T45.96XD..., subsequent encounter
    • T45.96XS..., sequela
• T45.APoisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs

  • T45.AXPoisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs

    • T45.AX1Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional)

      • T45.AX1A..., initial encounter
      • T45.AX1D..., subsequent encounter
      • T45.AX1S..., sequela
    • T45.AX2Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm

      • T45.AX2A..., initial encounter
      • T45.AX2D..., subsequent encounter
      • T45.AX2S..., sequela
    • T45.AX3Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault

      • T45.AX3A..., initial encounter
      • T45.AX3D..., subsequent encounter
      • T45.AX3S..., sequela
    • T45.AX4Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined

      • T45.AX4A..., initial encounter
      • T45.AX4D..., subsequent encounter
      • T45.AX4S..., sequela
    • T45.AX5Adverse effect of immune checkpoint inhibitors and immunostimulant drugs

      • T45.AX5A..., initial encounter
      • T45.AX5D..., subsequent encounter
      • T45.AX5S..., sequela
    • T45.AX6Underdosing of immune checkpoint inhibitors and immunostimulant drugs

      • T45.AX6A..., initial encounter
      • T45.AX6D..., subsequent encounter
      • T45.AX6S..., sequela